Deep Medicine Acquisition Corp.
NASDAQ:DMAQ
2.96 (USD) • At close January 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 0.577 | -0.27 | -0.262 | -0.658 | 0.577 | -0.166 | -0.154 | -0.183 | -0.135 | -0.079 | -0.016 | -0.059 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | 0.092 | 0.319 | 0.387 | 0.176 | 0.524 | 0.101 | 0.077 | -0.287 | -0.093 | 0.014 | 0.047 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| -0.577 | -0.091 | -0.111 | -0.096 | -1.061 | -0.552 | -0.115 | 0.006 | -0.002 | 0 | 0 | 0 |
| Operating Cash Flow
| 0.577 | -0.269 | -0.054 | -0.367 | -0.307 | -0.193 | -0.169 | -0.1 | -0.424 | -0.171 | -0.002 | -0.013 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 2.914 | -0.2 | 120.935 | -0.51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 2.914 | -0.2 | 120.935 | -0.51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 12.51 | 13.271 | 0 | -25.78 | 12.51 | 13.271 | 0 | 0 | 0 | 0 | 0 | 0.05 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -121.035 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -12.51 | -13.271 | 0.2 | -95.154 | 109.79 | -13.271 | 0 | 0 | 128.84 | 0 | 0 | 0.463 |
| Financing Cash Flow
| 12.51 | -2.83 | 0.2 | -120.935 | 1.265 | 13.271 | 0 | 0 | 128.84 | 0 | 0 | 0.513 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 13.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 13.087 | -0.185 | -0.054 | -0.367 | 0.448 | -0.193 | -0.169 | -0.1 | 0.651 | -0.171 | -0.002 | 0.5 |
| Cash At End Of Period
| 13.087 | 0.357 | 0.542 | 0.596 | 0.962 | 0.515 | 0.708 | 0.877 | 0.977 | 0.326 | 0.498 | 0.5 |